Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma

Author:

Cloughesy Timothy F.1,Landolfi Joseph2,Hogan Daniel J.3,Bloomfield Stephen2,Carter Bob4,Chen Clark C.4,Elder J. Bradley5,Kalkanis Steven N.6,Kesari Santosh4,Lai Albert1,Lee Ian Y.6,Liau Linda M.1,Mikkelsen Tom6,Nghiemphu Phioanh Leia1,Piccioni David4,Walbert Tobias6,Chu Alice3,Das Asha3,Diago Oscar R.3,Gammon Dawn3,Gruber Harry E.3,Hanna Michelle78,Jolly Douglas J.3,Kasahara Noriyuki9,McCarthy David7,Mitchell Leah3,Ostertag Derek3,Robbins Joan M.3,Rodriguez-Aguirre Maria3,Vogelbaum Michael A.10

Affiliation:

1. Department of Neuro-Oncology and Department of Neurosurgery, 710 Westwood Plaza, University of California, Los Angeles, Los Angeles, CA 90095, USA.

2. New Jersey Neuroscience Institute, John F. Kennedy Medical Center, 65 James Street, Edison, NJ 08820, USA.

3. Tocagen Inc., 3030 Bunker Hill Street, San Diego, CA 92109, USA.

4. Moores Cancer Center, Department of Neurosciences, University of California, San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA.

5. Ohio State University Wexner Medical Center, 410 West 10th Avenue, Columbus, OH 43210, USA.

6. Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202, USA.

7. Ribomed Biotechnologies Inc., 3030 Bunker Hill Street, San Diego, CA 92109, USA.

8. University of Arizona Cancer Center, 1515 North Campbell Avenue, Tucson, AZ 85724, USA.

9. Department of Cell Biology and Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

10. Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Abstract

Toca 511 and Toca FC show promising results in treating recurrent high-grade glioma, and a specific molecular signature correlates with treatment-related survival.

Funder

Accelerate Brain Cancer Cure Foundation

National Brain Tumor Society

American Brain Tumor Association

Musella Foundation

Voices Against Brain Cancer

National Institute of Neurological Disorders and Stroke

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Cited by 161 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3